Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05872828
NCT05872828
Enrolling By Invitation
Not Applicable

Anxiety, Depression, Immune Function and Quality of Life Among Chinese Liver Cancer Patients in the COVID-19 Pandemic Era

The Nethersole School of Nursing1 site in 1 country120 target enrollmentApril 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsLiver Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Cancer
Sponsor
The Nethersole School of Nursing
Enrollment
120
Locations
1
Primary Endpoint
Anxiety score
Status
Enrolling By Invitation
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of this cross-sectional study is to investigate the prevalence and risk factors of anxiety and depression and their relationships with immune functions and quality of life among liver cancer patients in the COVID-19 pandemic era. The objectives of this study are:

  1. To examine the prevalence of anxiety and depression among patients with liver cancer during the COVID-19 pandemic.
  2. To identify risk factors associated with anxiety and depression among these patients.
  3. To determine the association between anxiety, depression, immune function, and quality of life among liver cancer patients.

Participants will be asked to fill a digital questionnaire.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
April 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Nethersole School of Nursing
Responsible Party
Principal Investigator
Principal Investigator

Hua Yin

Principal Investigator

The Nethersole School of Nursing

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Anxiety score

Time Frame: Baseline

Participants' anxiety status with HADS

Depression score

Time Frame: Baseline

Participants' depression status with HADS

Secondary Outcomes

  • Quality of life score (The EORTC QLQ-C30)(Baseline)
  • Immune variables 3(Baseline)
  • Immune variables 6(Baseline)
  • Quality of life score (The EORTC QLQ-HCC18)(Baseline)
  • Immune variables 1(Baseline)
  • Immune variables 2(Baseline)
  • Immune variables 4(Baseline)
  • Immune variables 5(Baseline)
  • Immune variables 8(Baseline)
  • Immune variables 7(Baseline)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Risk Factors of Anxiety and Depression in Patients With Herpes Zoster NeuralgiaHerpes Zoster
NCT06449547Huazhong University of Science and Technology600
Completed
Not Applicable
Epidemiology and Prevention of Anxiety and Depression in Parents of Hospitalized NeonatesDepression
NCT01310634Nanjing Medical University600
Not yet recruiting
Not Applicable
Correlations Between Symptoms of Anxiety And/or Depression with Dysphagia Severity LevelDysphagiaAnxietyDepression
NCT06587555Universitas Padjadjaran30
Completed
Not Applicable
Role of Anxio-depressive History on Return to Work and Sport After Rotator Cuff SurgeryAnxiety Depression Disorder
NCT05531929University Hospital, Strasbourg, France212
Completed
Not Applicable
Anxiety in Relation to Nausea and Vomiting in PregnancyNausea GravidarumAnxiety
NCT06059794Ain Shams Maternity Hospital102